Inventor · disambiguated record
Yoshiro Ishiwata
Also filed as: ISHIWATA YOSHIRO
20 granted patents·2 pending applications·152 citations·filing 1982–2023
94Inventor score
Files withSANWA KAGAKU KENKYUSHO CO10TELIK INC5IDAC THERANOSTICS INC3UNIV TOKYO3VITAMIN KENKYUSO KK1
Top patents by PatentIndex Score
22 records- 0185US4528184APolymer-metal complexes containing quaternary nitrogen atoms used in the treatment of hypercholesteremiaVITAMIN KENKYUSO KK·Filed 1982·Granted Jul 9, 1985·36 cites·22 claims
- 0282US7297696B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2004·Granted Nov 20, 2007·18 cites·33 claims
- 0381US11572393B2HMGN partial peptide and cancer therapy using the sameUNIV TOKYO·Filed 2019·Granted Feb 7, 2023·2 cites·21 claims
- 0480US6962926B2Antagonist of MCP-1 function, and compositions and methods of use thereofSANWA KAGAKU KENKYUSHO CO·Filed 2003·Granted Nov 8, 2005·17 cites·20 claims
- 0580US6670364B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2002·Granted Dec 30, 2003·14 cites·65 claims
- 0677US6677365B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2002·Granted Jan 13, 2004·11 cites·40 claims
- 0775US6809113B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2002·Granted Oct 26, 2004·8 cites·40 claims
- 0873US10746726B2Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredientUNIV TOKYO·Filed 2015·Granted Aug 18, 2020·1 cites·10 claims
- 0970US11919932B2HMGN partial peptide and cancer therapy using the sameUNIV TOKYO·Filed 2023·Granted Mar 5, 2024·0 cites·18 claims
- 1066US5356880AGlycyrrhetinic acid derivativesSANWA KAGAKU KENKYUSHO CO·Filed 1992·Granted Oct 18, 1994·10 cites·7 claims
- 1164US6998407B2Antagonists of MCP-1 function and methods of use thereofSANWA KAGAKU KENKYUSHO CO·Filed 2003·Granted Feb 14, 2006·2 cites·24 claims
- 1262US6992086B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2003·Granted Jan 31, 2006·1 cites·26 claims
- 1352US2019125867A1Therapeutic agent for solid cancerIDAC THERANOSTICS INC·Filed 2018·Application pending·0 cites
- 1446US5340806AComposition containing organogermanium compound and immunity adjusting agent comprising the compositionSANWA KAGAKU KENKYUSHO CO·Filed 1993·Granted Aug 23, 1994·11 cites·6 claims
- 1546US2017165364A1Therapeutic agent for solid cancerIDAC THERANOSTICS INC·Filed 2015·Application pending·0 cites
- 1644US5730971APotentiator for interferon and an antiviral activity-potentiating composition containing interferon and its potentiatorSANWA KAGAKU KENKYUSHO CO·Filed 1994·Granted Mar 24, 1998·6 cites·6 claims
- 1739US5560925AMethod of treating wartSANWA KAGAKU KENKYUSHO CO·Filed 1994·Granted Oct 1, 1996·3 cites·4 claims
- 1834US11168137B2Method for reducing side effects of immune checkpoint control agentIDAC THERANOSTICS INC·Filed 2015·Granted Nov 9, 2021·0 cites·15 claims
- 1934US5336688AComposition containing organogermanium compound and immunity adjusting agents comprising the compositionsSANWA KAGAKU KENKYUSHO CO·Filed 1993·Granted Aug 9, 1994·4 cites·2 claims
- 2034US5279835ABinder-free orally administrable tablet containing 3-oxygermylpropionic acidSANWA KAGAKU KENKYUSHO CO·Filed 1992·Granted Jan 18, 1994·4 cites·1 claims
- 2133US5621003AMaillard reaction inhibitorSANWA KAGAKU KENKYUSHO CO·Filed 1995·Granted Apr 15, 1997·1 cites·2 claims
- 2228US5260056AComposition for enhancing biosynthesis of interferonSANWA KAGAKU KENKYUSHO CO·Filed 1991·Granted Nov 9, 1993·3 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Yoshiro Ishiwata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →